Aprepitant injectable formulations
US9968614B2 · kind B2 · utility
0Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2017 |
| Grant date | May 15, 2018 |
| Priority date | — |
| Expiry date | Jan 30, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aqueous stable and ready-to-use formulation of aprepitant is prepared. Especially preferred formulations comprise a synergistic combination of a co-solvent and a surfactant and may further include a secondary co-solvent. Among other advantages of contemplated formulations, aprepitant is dissolved at high concentrations and remains dissolved and stable, even over prolonged periods of time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.